Composition

Each mL solution contains 100 units insulin degludec/insulin aspart* in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart). One pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 mL solution. *Produced in Saccharomyces cerevisiae by recombinant DNA technology  

ATC Code

A10AD06  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

3 mL x 1's; 3 mL x 5's (in pre-filled pens)  

Product Description

Solution for injection in pre-filled pen. Clear, colourless, neutral solution

Manufacturer Name

Novo Nordisk A/S

Manufacturer Country

DENMARK  

Approval Date

2023-06-06  

Expiry Date

2028-05-30